U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833878) titled 'Chinese Hemoptysis Registry Study (CHORE)' on Sept. 16.
Brief Summary: This is a prospective, multicenter, observational registry study of hemoptysis in China. Hospitalized patients with active hemoptysis who undergo vascular interventional diagnosis and therapy will be consecutively enrolled from tertiary hospitals across China. Baseline clinical, imaging, angiographic, procedural, and in-hospital outcome data will be collected, and patients will be followed at 1 and 3 months and every 6 months for at least 2 years. The study aims to describe the real-world epidemiology and etiology spectrum of hemoptysis in China, evaluate short-...